Octreotide infusion pump in patients with functional neuroendocrine tumors and refractory hormonal syndrome

Octreotide infusion pump in patients with functional neuroendocrine tumors and refractory hormonal syndrome

Objective: To evaluate clinical outcomes, safety and survival measures of octreotide infusion pump (OIP) therapy in patients with metastatic neuroendocrine tumors (NETs) and refractory hormonal syndrome. Design: A retrospective analysis was conducted using data from patients treated with OIP therapy...

Full description

Saved in:
Bibliographic Details
Main Authors: Kalyan Mansukhbhai Shekhda, Eleni Armeni, Dalvinder Mandair, Aspasia Manta, George Parker, Akanksha Sarma, Aimee Hayes, Martyn Caplin, Christos Toumpanakis
Format: Article
Language:English
Published: Bioscientifica 2025-05-01
Series:Endocrine Oncology
Subjects:
octreotide infusion pump
refractory hormonal syndrome
neuroendocrine tumors
carcinoid syndrome
Online Access:https://eo.bioscientifica.com/view/journals/eo/5/1/EO-25-0016.xml
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://eo.bioscientifica.com/view/journals/eo/5/1/EO-25-0016.xml

Similar Items